
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
For Contemporary Pediatrics, Dr Bobby Lazzara discusses a recent study published in Pediatrics that examined why kids and teens are committing suicide; how they are doing it; and what groups were most likely to do it.
For Contemporary Pediatrics, Dr Bobby Lazzara discusses a recent study published in Pediatrics that examined why kids and teens are committing suicide; how they are doing it; and what groups were most likely to do it.






